The Latest Cardiac and Vascular News
MOUNTAIN VIEW, Calif., May 29, 2019 /PRNewswire/ — AliveCor, the leader in FDA-cleared consumer electrocardiogram (ECG) technology, and Best Buy Co., Inc. (NYSE: BBY) today announced a strategic partnership, bringing AliveCor’s products to select Best Buy stores across the country. This is the first time AliveCor’s products will be sold in consumer electronics stores […]
MOUNTAIN VIEW, Calif., May 13, 2019 /PRNewswire/ — AliveCor, the leader in FDA-cleared consumer electrocardiogram technology (ECG), today announced its third FDA clearance in three months, making KardiaMobile 6L the world’s first available six-lead personal ECG device. This highly anticipated clearance gives patients and their physicians an even more detailed view into patients’ […]
MOUNTAIN VIEW, Calif., Feb. 26, 2019 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced Jacqueline Shreibati, MD, MS, FACC, as Chief Medical Officer of the company. In her new role, Dr. Shreibati will lead AliveCor’s medical roadmap, developing innovative products that employ digital intelligence to improve heart care […]
ALEXANDRIA, Va. and MOUNTAIN VIEW, Calif., Jan. 28, 2019 /PRNewswire/ — Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $20 million senior secured term loan to AliveCor, Inc., a privately held company focused on using artificial intelligence to improve cardiac […]
MOUNTAIN VIEW, Calif., Nov. 12, 2018 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, has announced that a research version of its mobile technology can identify ST-elevation myocardial infarction (STEMI), the most severe form of heart attack. The findings of the ST LEUIS International Multicenter Study, to be announced at […]
MOUNTAIN VIEW, Calif., Sept. 10, 201 /PRNewswire/ — AliveCor, recently recognized as the Most Innovative Company in Artificial Intelligence, today announced that the U.S. Food and Drug Administration has given the company’s KardiaK Software Platform the rarely granted designation of “Breakthrough Device.” This designation means that the FDA will consider the technology […]
MOUNTAIN VIEW, Calif., April 5, 2018 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, announced today that it had surpassed the milestone of 25 million recorded ECGs – by far the largest data set ever collected by any consumer ECG. The company also announced that its KardiaBand product, paired with […]
ORLANDO, Fla., March 12, 2018 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced findings from two new studies that further support the use of its portable ECG devices to provide groundbreaking health monitoring capabilities. A new Cleveland Clinic study — which marks the first time Apple […]
MOUNTAIN VIEW, Calif., Dec. 12, 2017 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (EKG) technology, today announced issuance of a U.S. patent which covers the use of data collected from wearable devices as a means of assisting diagnoses of heart arrhythmias, including those that may be asymptomatic. U.S. Patent […]
MOUNTAIN VIEW, Calif., Sept. 6, 2017 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (EKG) technology, today announced the results of four clinical research presentations that demonstrate that AliveCor’s hyper-fast, 30 second, digital EKG can positively impact and potentially even save the lives of millions of people around the world who suffer […]
